This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, B. J.
Right arrow Articles by Kaplan, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, B. J.
Right arrow Articles by Kaplan, G.

 Previous Article  |  Next Article 

Infect Immun, June 1998, p. 2426-2433, Vol. 66, No. 6
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Differential Gene Expression in Response to Adjunctive Recombinant Human Interleukin-2 Immunotherapy in Multidrug-Resistant Tuberculosis Patients

Barbara J. Johnson,1 Iris Estrada,2,dagger Zhu Shen,1 Stan Ress,3 Paul Willcox,3 M. Joseph Colston,2 and Gilla Kaplan1,*

Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York, New York1; Division of Mycobacterial Research, National Institute for Medical Research, London, United Kingdom2; and Department of Medicine, University of Cape Town, Cape Town, South Africa3

Received 7 July 1997/Returned for modification 3 September 1997/Accepted 28 February 1998

Administration of low-dose recombinant human interleukin 2 (rhuIL-2) in combination with multidrug chemotherapy to patients with multidrug-resistant tuberculosis (MDR TB) induces measurable changes in in vitro immune response parameters which are associated with changes in the clinical and bacteriologic status of the patients. To determine the molecular basis of these changes, we have used semiquantitative reverse transcriptase-initiated PCR (RT-PCR) and differential display technology. During rhuIL-2 treatment of MDR TB patients, decreased levels of gamma interferon (IFN-gamma ) mRNA in peripheral blood mononuclear cells (PBMC) relative to baseline levels were observed. However, at the site of a delayed-type hypersensitivity (DTH) response to purified protein derivative of tuberculin (PPD), the expression of cellular IFN-gamma and IL-2 mRNAs was increased during rhuIL-2 therapy. Levels of other cytokine mRNAs were not significantly affected by rhuIL-2 administration. Using differential-display RT-PCR, we identified several genes expressed at the DTH skin test site which were up- or down-regulated during rhuIL-2 treatment. Cytochrome oxidase type I mRNA was increased in response to rhuIL-2 therapy relative to baseline levels, as was heterogeneous nuclear ribonuclear protein G mRNA. CD63, clathrin heavy chain, and beta -adaptin mRNAs, all of which encode proteins associated with the endocytic vacuolar pathway of cells, were also differentially regulated by rhuIL-2 administration. The differential effects of IL-2 were confirmed in vitro by using PBMC obtained from PPD-positive individuals stimulated with Mycobacterium tuberculosis and IL-2. The differential expression of genes may provide a surrogate marker for leukocyte activation at a mycobacterial antigen-specific response site and for the development of an enhanced antimicrobial response which may result in improved outcomes in MDR TB patients.

* Corresponding author. Mailing address: Laboratory of Cellular Physiology and Immunology, Rockefeller University, Box 176, New York, NY 10021. Phone: (212) 327-8375. Fax: (212) 327-8875. E-mail: kaplang{at}rockvax.rockefeller.edu.

dagger Present address: Instituto Politecnico Nacional, Departmento de Immunologia, Mexico City, Mexico.

Infect Immun, June 1998, p. 2426-2433, Vol. 66, No. 6
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Djoba Siawaya, J. F., Bapela, N. B., Ronacher, K., Beyers, N., van Helden, P., Walzl, G. (2008). Differential Expression of Interleukin-4 (IL-4) and IL-4{delta}2 mRNA, but Not Transforming Growth Factor Beta (TGF-{beta}), TGF-{beta}RII, Foxp3, Gamma Interferon, T-bet, or GATA-3 mRNA, in Patients with Fast and Slow Responses to Antituberculosis Treatment. CVI 15: 1165-1170 [Abstract] [Full Text]  
  • Miles, D. J. C., van der Sande, M., Crozier, S., Ojuola, O., Palmero, M. S., Sanneh, M., Touray, E. S., Rowland-Jones, S., Whittle, H., Ota, M., Marchant, A. (2008). Effects of Antenatal and Postnatal Environments on CD4 T-Cell Responses to Mycobacterium bovis BCG in Healthy Infants in The Gambia. CVI 15: 995-1002 [Abstract] [Full Text]  
  • Frias-Lopez, J., Bonheyo, G. T., Fouke, B. W. (2004). Identification of Differential Gene Expression in Bacteria Associated with Coral Black Band Disease by Using RNA-Arbitrarily Primed PCR. Appl. Environ. Microbiol. 70: 3687-3694 [Abstract] [Full Text]  
  • Ewing, R. M., Kahla, A. B., Poirot, O., Lopez, F., Audic, S., Claverie, J.-M. (1999). Large-Scale Statistical Analyses of Rice ESTs Reveal Correlated Patterns of Gene Expression. Genome Res 9: 950-959 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»